Table 2.
Clinical features of each FSGS variant at the time of biopsy
| Characteristics | Tip (n = 4) | Collapsing (n = 2) | Cellular (n = 15) | Perihilar (n = 4) | NOS (n = 4) |
|---|---|---|---|---|---|
| Age (yr) | 54.0 ± 13.0 (37–74) | 23.0 ± 1.0 (22–24) | 61.0 ± 13.0 (32–83) | 32.0 ± 15.0 (18–56) | 46.0 ± 20.0 (16–70) |
| Male/female (n) | 3/1 | 0/2 | 9/6 | 3/1 | 4/0 |
| Time to biopsy (mo) | 2.0 ± 2.3 | 156.0 ± 0.0 | 20.0 ± 47.6 | 152.0 ± 99.12 | 135.0 ± 72.7 |
| Nephrotic syndrome (%) | 100 | 100 | 93.3 | 25 | 50 |
| eGFR (ml/min per 1.73 m2) | 72.5 ± 6.6 | 23.1 ± 4.7 | 44.2 ± 24.1 | 50.6 ± 9.5 | 41.0 ± 14.7 |
eGFR, estimated glomerular filtration rate; FSGS, focal segmental glomerular sclerosis; NOS, not otherwise specified.
Quantitative variables are mean ± SD.